financetom
Business
financetom
/
Business
/
Match Group forecasts quarterly revenue below estimates as payers continue to slide
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Match Group forecasts quarterly revenue below estimates as payers continue to slide
Nov 4, 2025 1:41 PM

(Reuters) -Match Group ( MTCH ) forecast fourth-quarter revenue below analysts' estimates on Tuesday, underscoring ongoing challenges in its turnaround efforts as the Tinder parent struggles to convert casual swipers into loyal, paying users.

The company, which also owns popular dating platforms OkCupid and Plenty of Fish, has invested heavily in rolling out new features and integrating advanced artificial intelligence features designed to revitalize user engagement and bolster security. However, these efforts have yet to produce substantial gains, with user growth falling short of expectations.

The online dating sector itself is grappling with "swiping fatigue," pushing younger consumers to seek more interactive and meaningful ways to connect. 

This shift has reshaped the online dating industry, leading to a fragmented market and intensifying competition. Rivals such as Bumble, along with numerous niche apps, are forced to rapidly evolve their offerings to better align with changing user demands.

Match Group's ( MTCH ) ambitious AI-driven security enhancements, which include facial verification and automated profile authenticity checks aimed at addressing growing concerns over fake profiles and online dating safety, have been widely praised as industry-leading, but so far have not translated into measurable improvements in user engagement or retention.

For the third quarter, the company posted a 5% decrease in its paying users to 14.5 million.

While Hinge, often hailed as Match's rising star, continues to demonstrate robust growth, it remains too small to offset broader struggles at Tinder, the company's flagship app. 

The company forecasts fourth-quarter revenue between $865 and $875 million, widely missing analysts' estimates of $882.8 million, according to data compiled by LSEG.

Revenue for the third quarter came in at $914 million, slightly below estimates of $915 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cava Group Insider Sold Shares Worth $13,091,201, According to a Recent SEC Filing
Cava Group Insider Sold Shares Worth $13,091,201, According to a Recent SEC Filing
Sep 1, 2024
04:08 PM EDT, 08/30/2024 (MT Newswires) -- Ronald M Shaich, Director, on August 28, 2024, sold 110,053 shares in Cava Group ( CAVA ) for $13,091,201. Following the Form 4 filing with the SEC, Shaich has control over a total of 1,463,941 shares of the company, with 6,307 shares held directly and 1,457,634 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1639438/000162828024038953/xslF345X05/wk-form4_1725048102.xml Price: 114.04,...
Market Chatter: LCM Partners to Join KKR in Acquiring $2.1 Billion Loan Portfolio From Orange Bank
Market Chatter: LCM Partners to Join KKR in Acquiring $2.1 Billion Loan Portfolio From Orange Bank
Sep 1, 2024
03:06 PM EDT, 08/29/2024 (MT Newswires) -- LCM Partners is joining a bid by KKR (KKR) to buy about 1.9 billion euros ($2.1 billion) of loans from Orange Bank, Bloomberg reported Thursday. LCM Partners will take around a third of the transaction which is likely to be completed in the coming days, the report said, citing people familiar with the...
Why BioCardia (BCDA) Stock Is Up 95% Today
Why BioCardia (BCDA) Stock Is Up 95% Today
Sep 1, 2024
BioCardia Inc ( BCDA ) shares are trading higher by 95% to $4.30 during Thursday’s session after the FDA cleared the company to market its Morph DNA Steerable Introducer product family. What Happened: The product family is designed to facilitate the introduction of medical instruments, such as catheters and guidewires, into the peripheral vasculature and heart chambers during various cardiovascular...
Market Chatter: Apple Discusses Investment in OpenAI Funding Round
Market Chatter: Apple Discusses Investment in OpenAI Funding Round
Sep 1, 2024
02:15 PM EDT, 08/29/2024 (MT Newswires) -- Apple ( AAPL ) is discussing potential investment in Microsoft ( MSFT ) -backed OpenAI as part of a fundraising round that will push OpenAI's valuation over $100 billion, The Wall Street Journal reported Thursday, citing people familiar with the situation. The funding round worth several billion dollars will likely include Microsoft (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved